Concepedia

Luisa Shin Ogawa

LS

11

Publications

860

Citations

10

H-Index

2011

Active since

Affiliations

Synta Pharmaceuticals (United States)(Current)

Cairn University

VA Boston Healthcare System

Fox Chase Cancer Center

Luisa Shin Ogawa is an author at Synta Pharmaceuticals (United States) specializing in medicine, pharmacology, and cancer research.

Top concepts

Publications per year

2011–2018

11

Publications

11

The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells

Masazumi Nagai, Nha Huu Vo, Luisa Shin Ogawa et al. · Free Radical Biology and Medicine · 2012 · 330 citations

, , +10

Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy

Weiwen Ying, Zhenjian Du, Lijun Sun et al. · Molecular Cancer Therapeutics · 2011 · 227 citations

, , +19

FGFR3 Translocations in Bladder Cancer: Differential Sensitivity to HSP90 Inhibition Based on Drug Metabolism

Jaime Acquaviva, Suqin He, Chaohua Zhang et al. · Molecular Cancer Research · 2014 · 75 citations

A rat retinal damage model predicts for potential clinical visual disturbances induced by Hsp90 inhibitors

Dan Zhou, Yuan Liu, Josephine Ye et al. · Toxicology and Applied Pharmacology · 2013 · 71 citations · Full text

UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespib

Hannes Landmann, David A. Proia, Sen He et al. · Cell Death and Disease · 2014 · 41 citations · Full text

Rows per page

1–5 of 11